A lifetime of possibilities.

Our Purpose

Vitara is developing a therapeutic platform to support premature infants. Our innovative platform is inspired by natural physiological processes and hopes to transform neonatal care. Our goal is to protect more preterm infants and improve their quality of life by reducing mortality and comorbidities.

Our Team

  • JAMES S. MCGLONE MS, MBA

    PRESIDENT & CEO

  • ALAN FLAKE MD, FACS, FAAP

    CO-INVENTOR, MEDICAL ADVISOR

  • MARCUS G. DAVEY, PHD

    CO-INVENTOR, VP PRECLINICAL RESEARCH

  • JOHN B. KELLY

    CHIEF FINANCIAL OFFICER

  • MONICA FERRANTE, DPA

    VP REGULATORY, QUALITY, CLINICAL

  • CHRIS GREGORY, PHD

    VP RESEARCH & DEVELOPMENT

  • ROSALEEN OSKANIAN JD, MBA, CIPPE, CIPM

    GENERAL COUNSEL & CORPORATE SECRETARY